"Nuclear medicines, like radioligand therapy, could be transformative for cancer care in Australia. Establishing clear pathways for market access and a thriving nuclear medicine industry will be key to enabling Australian patients to access these new treatment options," said Novartis country president Matt Zeller.
New Novartis-backed report identifies nuclear medicine opportunity but calls for change
April 19, 2024 Latest NewsBioPharmaNews of the DayLatest Video
New Stories
-
'The truth is more that they are the heroes of every walk of life'
May 6, 2024 - - Latest News -
HTA review's final report now sits with Health Minister Mark Butler
May 6, 2024 - - Latest News -
The secrecy of the process was wrong, but the report is now the minister's to release
May 6, 2024 - - Latest News -
The Week in Review Podcast - 3 May
May 3, 2024 - - Podcast -
New data shows significant increase in the number of pharmacies supplying naloxone
May 3, 2024 - - Latest News -
CSL Seqirus secures local rights to new adrenaline nasal spray
May 3, 2024 - - Latest News -
Industry applauds funding commitment for National One Stop Shop for clinical trials
May 3, 2024 - - Latest News